ZA969564B - Synergistic herbicidal mixtures - Google Patents

Synergistic herbicidal mixtures

Info

Publication number
ZA969564B
ZA969564B ZA969564A ZA969564A ZA969564B ZA 969564 B ZA969564 B ZA 969564B ZA 969564 A ZA969564 A ZA 969564A ZA 969564 A ZA969564 A ZA 969564A ZA 969564 B ZA969564 B ZA 969564B
Authority
ZA
South Africa
Prior art keywords
synergistic herbicidal
herbicidal mixtures
mixtures
synergistic
herbicidal
Prior art date
Application number
ZA969564A
Other languages
English (en)
Inventor
Richard Rees
Juergen Bohner
Eberhard Richter
Original Assignee
Hoechst Schering Agrevo Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Schering Agrevo Gmbh filed Critical Hoechst Schering Agrevo Gmbh
Publication of ZA969564B publication Critical patent/ZA969564B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA969564A 1995-11-15 1996-11-14 Synergistic herbicidal mixtures ZA969564B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19544393A DE19544393A1 (de) 1995-11-15 1995-11-15 Synergistische herbizide Mischungen

Publications (1)

Publication Number Publication Date
ZA969564B true ZA969564B (en) 1997-05-15

Family

ID=7778639

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA969564A ZA969564B (en) 1995-11-15 1996-11-14 Synergistic herbicidal mixtures

Country Status (18)

Country Link
US (1) US6013605A (xx)
EP (1) EP0863705B1 (xx)
JP (1) JP3920341B2 (xx)
KR (1) KR100427960B1 (xx)
CN (1) CN1084148C (xx)
AU (1) AU711841B2 (xx)
BR (1) BR9611478A (xx)
CA (1) CA2236592C (xx)
DE (2) DE19544393A1 (xx)
ES (1) ES2178720T3 (xx)
MX (1) MX9803824A (xx)
MY (1) MY114731A (xx)
RU (1) RU2170017C2 (xx)
TR (1) TR199800794T2 (xx)
TW (1) TW355125B (xx)
UA (1) UA48203C2 (xx)
WO (1) WO1997017852A1 (xx)
ZA (1) ZA969564B (xx)

Families Citing this family (243)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836684A1 (de) * 1998-08-13 2000-02-17 Hoechst Schering Agrevo Gmbh Herbizide Mittel für tolerante oder resistente Reiskulturen
KR100338621B1 (ko) * 2000-01-24 2002-05-30 전광술 제초제 및 그 제조방법
US20070160576A1 (en) 2001-06-05 2007-07-12 Genentech, Inc. IL-17A/F heterologous polypeptides and therapeutic uses thereof
MXPA03011985A (es) 2001-06-20 2004-03-26 Genentech Inc Composiciones y metodos para el diagnostico y tratamiento de tumores.
EP1420644B1 (de) 2001-08-23 2006-05-31 Bayer CropScience S.A. Substituierte propargylamine
KR101008758B1 (ko) 2001-09-18 2011-01-14 제넨테크, 인크. 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물
EP2067472A1 (en) 2002-01-02 2009-06-10 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
KR100429139B1 (ko) * 2002-02-28 2004-04-29 한국화학연구원 싸이할로호프와 메타미호프를 유효성분으로 하는 제초제조성물 및 이를 이용하여 화본과 잡초를 방제하는 방법
NZ535925A (en) 2002-04-16 2008-06-30 Genentech Inc An isolated antibody that binds to a particular polypeptide
EP2305710A3 (en) 2002-06-03 2013-05-29 Genentech, Inc. Synthetic antibody phage libraries
WO2004091658A1 (en) 2003-04-04 2004-10-28 Genentech, Inc. High concentration antibody and protein formulations
US6849579B2 (en) * 2003-06-25 2005-02-01 Pbi Gordon Corporation Synergistic quinclorac herbicidal compositions
SI2784084T2 (sl) 2003-07-08 2024-02-29 Novartis Pharma Ag Antagonistična protitelesa proti IL-17 A/F heterolognim polipeptidom
EP2161283B1 (en) 2003-11-17 2014-06-04 Genentech, Inc. Compositions comprising antibodies against CD79b conjugated to a growth inhibitory agent or cytotoxic agent and methods for the treatment of tumor of hematopoietic origin
JP4570890B2 (ja) * 2004-03-26 2010-10-27 協友アグリ株式会社 除草剤組成物
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
ES2710439T3 (es) 2005-01-21 2019-04-25 Genentech Inc Dosificación fija de anticuerpos HER
US20090136505A1 (en) 2005-02-23 2009-05-28 Johanna Bentz Intranasal Administration of Active Agents to the Central Nervous System
AU2006216732C1 (en) 2005-02-23 2017-07-20 Genentech, Inc. Extending time to disease progression or survival in cancer patients using a HER dimerization inhibitor
WO2006091332A2 (en) 2005-02-23 2006-08-31 Alza Corporation Intranasal administration of active agents to the central nervous system
KR101373140B1 (ko) 2005-03-03 2014-03-12 씨오브이엑스 테크놀로지스 아일랜드 리미티드 항-혈관형성 화합물
JP2008541781A (ja) 2005-06-06 2008-11-27 ジェネンテック・インコーポレーテッド 異なる遺伝子に対するトランスジェニック動物、および遺伝子の特徴づけのためのその使用
EP1995321A2 (en) 2005-08-15 2008-11-26 Genentech, Inc. Gene disruptions, compositions and methods relating thereto
EP1962584A2 (en) 2005-11-21 2008-09-03 Genentech, Inc. Novel gene disruptions, compositions and methods relating thereto
CA2638821A1 (en) 2006-02-17 2007-10-11 Genentech, Inc. Gene disruptons, compositions and methods relating thereto
MX2008011905A (es) 2006-03-21 2008-09-30 Genentech Inc Terapia de combinacion.
CA2647277A1 (en) 2006-04-05 2007-11-08 Genentech, Inc. Method for using boc/cdo to modulate hedgehog signaling
CA2649387A1 (en) 2006-04-19 2008-03-27 Genentech, Inc. Novel gene disruptions, compositions and methods relating thereto
MX2008015541A (es) 2006-06-06 2008-12-18 Genentech Inc Anticuerpos anti-dll4 y metodos que los usan.
US8874380B2 (en) 2010-12-09 2014-10-28 Rutgers, The State University Of New Jersey Method of overcoming therapeutic limitations of nonuniform distribution of radiopharmaceuticals and chemotherapy drugs
EP2057465A4 (en) 2006-08-09 2010-04-21 Homestead Clinical Corp SPECIFIC ORGAN PROTEINS AND METHODS OF USE
US10118970B2 (en) 2006-08-30 2018-11-06 Genentech, Inc. Multispecific antibodies
DK2089425T3 (da) 2006-11-10 2011-10-10 Covx Technologies Ireland Ltd Antiangiogene forbindelser
ES2379413T3 (es) 2007-02-22 2012-04-25 Genentech, Inc. Procedimientos para detectar la enfermedad inflamatoria del intestino
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
EP2592156B1 (en) 2007-06-08 2016-04-20 Genentech, Inc. Gene expression markers of tumor resistance to HER2 inhibitor treatment
US9845355B2 (en) 2007-07-16 2017-12-19 Genentech, Inc. Humanized anti-CD79b antibodies and immunoconjugates and methods of use
CN101802012B (zh) 2007-07-16 2014-08-06 健泰科生物技术公司 抗cd79b抗体和免疫偶联物及使用方法
CN101910414B (zh) 2007-11-07 2016-01-13 健泰科生物技术公司 用于评估b细胞淋巴瘤对抗cd40抗体治疗的响应性的方法和组合物
WO2010135521A2 (en) 2009-05-20 2010-11-25 Theraclone Sciences, Inc. Compositions and methods for the therapy and diagnosis of influenza
ES2395784T3 (es) 2007-11-12 2013-02-15 Theraclone Sciences, Inc. Composiciones y métodos para la terapia y diagnosis de la influenza
IL287292B (en) 2008-01-31 2022-09-01 Genentech Inc and fusion antibody-drug-cd79b engineered antibodies cysteine-
MX2010009885A (es) 2008-03-10 2010-11-30 Theraclone Sciences Inc Composiciones y métodos para la terapia y diagnóstico de citomegalovirus.
US20110123530A1 (en) 2008-03-31 2011-05-26 Arron Joseph R Compositions and methods for treating and diagnosing asthma
KR101361905B1 (ko) 2008-05-16 2014-02-21 제넨테크, 인크. 베타7 인테그린 길항제를 이용한 위장관 염증 장애의 치료를 평가하기 위한 바이오마커의 용도
DK2307051T3 (en) 2008-07-08 2015-04-20 Oncomed Pharm Inc Notch-binding substances, and antagonists and methods of use thereof
US8680020B2 (en) 2008-07-15 2014-03-25 Academia Sinica Glycan arrays on PTFE-like aluminum coated glass slides and related methods
CN101352171B (zh) * 2008-09-19 2012-07-04 北京燕化永乐农药有限公司 吡嘧磺隆与甲羧除草醚农药的除草剂组合物
ES2766257T3 (es) 2008-11-13 2020-06-12 Massachusetts Gen Hospital Métodos y composiciones para regular la homeostasis del hierro mediante la modulación de bmp-6
WO2010062857A1 (en) 2008-11-26 2010-06-03 Allergan, Inc. Klk-13 antibody inhibitor for treating dry eye
KR20220047668A (ko) 2008-12-09 2022-04-18 제넨테크, 인크. 항-pd-l1 항체 및 t 세포 기능을 향상시키기 위한 그의 용도
SI3260136T1 (sl) 2009-03-17 2021-05-31 Theraclone Sciences, Inc. Humani imunodeficientni virus (HIV)-nevtralizirajoča protitelesa
ES2572728T3 (es) 2009-03-20 2016-06-02 F. Hoffmann-La Roche Ag Anticuerpos anti-HER biespecíficos
SG174992A1 (en) 2009-04-01 2011-11-28 Genentech Inc Anti-fcrh5 antibodies and immunoconjugates and methods of use
AR075998A1 (es) 2009-04-01 2011-05-11 Genentech Inc Tratamiento de trastornos resistentes a insulina.composicion farmaceutica. uso. kit
US20100297127A1 (en) 2009-04-08 2010-11-25 Ghilardi Nico P Use of il-27 antagonists to treat lupus
MX2011010938A (es) 2009-04-18 2012-01-12 Genentech Inc Metodos para determinar la sensibilidad de linfoma de celula b al tratamiento con anticuerpos anti-cd40.
CN102459340A (zh) 2009-04-23 2012-05-16 特罗科隆科学有限公司 粒性白血细胞-巨噬细胞菌落-刺激因子(gm-csf)中和抗体
US20110038871A1 (en) 2009-08-11 2011-02-17 Veena Viswanth Ccr2 inhibitors for treating conditions of the eye
WO2011050194A1 (en) 2009-10-22 2011-04-28 Genentech, Inc. Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
WO2011056494A1 (en) 2009-10-26 2011-05-12 Genentech, Inc. Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations
WO2011056497A1 (en) 2009-10-26 2011-05-12 Genentech, Inc. Activin receptor type iib compositions and methods of use
WO2011056502A1 (en) 2009-10-26 2011-05-12 Genentech, Inc. Bone morphogenetic protein receptor type ii compositions and methods of use
EP2494356B1 (en) 2009-10-26 2017-03-15 Genentech, Inc. Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis
CA2781887C (en) 2009-11-30 2018-03-27 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
WO2011082187A1 (en) 2009-12-30 2011-07-07 Genentech, Inc. Methods for modulating a pdgf-aa mediated biological response
CA2787657A1 (en) 2010-02-23 2011-09-01 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
WO2011133931A1 (en) 2010-04-22 2011-10-27 Genentech, Inc. Use of il-27 antagonists for treating inflammatory bowel disease
JP2013525484A (ja) 2010-05-03 2013-06-20 ジェネンテック, インコーポレイテッド タンパク質含有製剤の粘度を低減させるために有用な組成物及び方法
DK2975409T3 (en) 2010-05-10 2018-12-17 Academia Sinica Zanamivir phosphonate congeners with anti-influenza activity and determination of oseltamivir sensitivity in influenza viruses
CN102265853A (zh) * 2010-06-04 2011-12-07 南京华洲药业有限公司 一种含灭草松和二氯喹啉酸的除草组合物及其应用
US20110311527A1 (en) 2010-06-16 2011-12-22 Allergan, Inc. IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS
EP2420250A1 (en) 2010-08-13 2012-02-22 Universitätsklinikum Münster Anti-Syndecan-4 antibodies
WO2012021786A2 (en) 2010-08-12 2012-02-16 Theraclone Sciences, Inc. Anti-hemagglutinin antibody compositions and methods of use thereof
EP2603526A1 (en) 2010-08-13 2013-06-19 Medimmune Limited Monomeric polypeptides comprising variant fc regions and methods of use
WO2012022734A2 (en) 2010-08-16 2012-02-23 Medimmune Limited Anti-icam-1 antibodies and methods of use
CA3201524A1 (en) 2010-08-31 2012-03-08 Theraclone Sciences, Inc. Human immunodeficiency virus (hiv)-neutralizing antibodies
WO2012092539A2 (en) 2010-12-31 2012-07-05 Takeda Pharmaceutical Company Limited Antibodies to dll4 and uses thereof
SG192727A1 (en) 2011-02-14 2013-09-30 Theraclone Sciences Inc Compositions and methods for the therapy and diagnosis of influenza
KR20140012131A (ko) 2011-03-15 2014-01-29 테라클론 사이언시스, 아이엔씨. 인플루엔자의 치료 및 진단을 위한 조성물 및 방법
CA2831732C (en) 2011-03-31 2019-12-31 Genentech, Inc. Use of a monoclonal anti-beta7 antibody for treating gastrointestinal inflammatory disorders
US20120308584A1 (en) 2011-05-08 2012-12-06 Legochem Biosciences, Inc. Protein-active agent conjugates and method for preparing the same
CN116948019A (zh) 2011-05-17 2023-10-27 洛克菲勒大学 人类免疫缺陷病毒中和抗体及其使用方法
WO2012170071A1 (en) 2011-06-06 2012-12-13 Elan Pharmaceuticas, Inc Mcam antagonists and methods of treatment
JP2013040160A (ja) 2011-07-01 2013-02-28 Genentech Inc 自己免疫疾患を治療するための抗cd83アゴニスト抗体の使用
WO2013015821A1 (en) 2011-07-22 2013-01-31 The Research Foundation Of State University Of New York Antibodies to the b12-transcobalamin receptor
US9120858B2 (en) 2011-07-22 2015-09-01 The Research Foundation Of State University Of New York Antibodies to the B12-transcobalamin receptor
US9493549B2 (en) 2011-07-25 2016-11-15 The Rockefeller University Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth
EP2736532B1 (en) 2011-07-25 2018-05-16 California Institute of Technology Compositions and methods for improving potency and breadth or hiv antibodies
US8822651B2 (en) 2011-08-30 2014-09-02 Theraclone Sciences, Inc. Human rhinovirus (HRV) antibodies
CA2863224A1 (en) 2012-01-09 2013-07-18 The Scripps Research Institute Ultralong complementarity determining regions and uses thereof
CN104411717A (zh) 2012-01-09 2015-03-11 斯克利普斯研究所 具有超长cdr3s的人源化抗体
JP2015506950A (ja) 2012-01-31 2015-03-05 ジェネンテック, インコーポレイテッド 抗ig−em1’抗体およびそれを用いる方法
JP2015514710A (ja) 2012-03-27 2015-05-21 ジェネンテック, インコーポレイテッド Her3阻害剤に関する診断及び治療
EP2831280B1 (en) 2012-03-27 2020-04-15 F.Hoffmann-La Roche Ag Methods of prognosing and diagnosing idiopathic pulmonary fibrosis
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
WO2013192589A1 (en) 2012-06-21 2013-12-27 California Institute Of Technology Antibodies targeting hiv escape mutants
WO2014018375A1 (en) 2012-07-23 2014-01-30 Xenon Pharmaceuticals Inc. Cyp8b1 and uses thereof in therapeutic and diagnostic methods
CA2880701A1 (en) 2012-08-18 2014-02-27 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
WO2014031762A1 (en) 2012-08-21 2014-02-27 Academia Sinica Benzocyclooctyne compounds and uses thereof
TWI660972B (zh) 2012-09-10 2019-06-01 愛爾蘭商尼歐托普生物科學公司 抗mcam抗體及相關使用方法
WO2014055824A1 (en) 2012-10-05 2014-04-10 Genentech, Inc. Methods for diagnosing and treating inflammatory bowel disease
PL2908912T3 (pl) 2012-10-18 2021-05-17 The Rockefeller University Szeroko neutralizujące przeciwciała anty-hiv
EP2911692B1 (en) 2012-10-26 2019-08-21 The University of Queensland Use of endocytosis inhibitors and antibodies for cancer therapy
WO2014160753A1 (en) 2013-03-27 2014-10-02 Genentech, Inc. Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
WO2014169076A1 (en) 2013-04-09 2014-10-16 Annexon,,Inc. Methods of treatment for neuromyelitis optica
EP3013365B1 (en) 2013-06-26 2019-06-05 Academia Sinica Rm2 antigens and use thereof
US9981030B2 (en) 2013-06-27 2018-05-29 Academia Sinica Glycan conjugates and use thereof
SG11201510316UA (en) 2013-07-09 2016-01-28 Annexon Inc Anti-complement factor c1q antibodies and uses thereof
CN111518199A (zh) 2013-07-18 2020-08-11 图鲁斯生物科学有限责任公司 具有超长互补决定区的人源化抗体
EP3022224A2 (en) 2013-07-18 2016-05-25 Fabrus, Inc. Antibodies with ultralong complementarity determining regions
AU2014317889B2 (en) 2013-09-06 2020-03-05 Academia Sinica Human iNKT cell activation using glycolipids with altered glycosyl groups
WO2015050959A1 (en) 2013-10-01 2015-04-09 Yale University Anti-kit antibodies and methods of use thereof
RU2732032C2 (ru) 2013-12-20 2020-09-10 Дженентек, Инк. Антитела с двойной специфичностью
CA2936488C (en) 2014-01-14 2022-05-03 The Medical College Of Wisconsin, Inc. Targeting clptm1l for treatment and prevention of cancer
EP3094352B1 (en) 2014-01-16 2020-09-23 Academia Sinica Compositions and methods for treatment and detection of cancers
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
WO2015116902A1 (en) 2014-01-31 2015-08-06 Genentech, Inc. G-protein coupled receptors in hedgehog signaling
WO2015148915A1 (en) 2014-03-27 2015-10-01 Academia Sinica Reactive labelling compounds and uses thereof
CA2939246A1 (en) 2014-03-27 2015-10-01 Genentech, Inc. Methods for diagnosing and treating inflammatory bowel disease
CN104012547A (zh) * 2014-05-07 2014-09-03 广东中迅农科股份有限公司 一种含有双唑草腈和氰氟草酯的除草组合物
CN104012549B (zh) * 2014-05-07 2016-08-17 广东中迅农科股份有限公司 一种含有双唑草腈和双草醚的除草组合物
EP3888690A3 (en) 2014-05-16 2021-10-20 MedImmune, LLC Molecules with altered neonate fc receptor binding having enhanced therapeutic and diagnostic properties
US20150344585A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-cd20 glycoantibodies and uses thereof
EP3149037A4 (en) 2014-05-27 2018-01-10 Academia Sinica Anti-her2 glycoantibodies and uses thereof
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
EP3904388A1 (en) 2014-05-27 2021-11-03 Academia Sinica Fucosidase from bacteroides and methods using the same
KR102494193B1 (ko) 2014-05-28 2023-01-31 아카데미아 시니카 항-tnf-알파 글리코항체 및 이의 용도
PL3148581T3 (pl) 2014-05-30 2020-05-18 Henlix Biotech Co., Ltd. Przeciwciała przeciwko receptorowi naskórkowego czynnika wzrostu (EGFR)
AU2015300787A1 (en) 2014-08-08 2017-02-02 Alector Llc Anti-TREM2 antibodies and methods of use thereof
KR102422375B1 (ko) 2014-09-08 2022-07-18 아카데미아 시니카 당지질을 사용한 인간 iNKT 세포 활성화
CN104255750A (zh) * 2014-09-10 2015-01-07 广东中迅农科股份有限公司 含有双唑草腈和丙草胺的除草组合物
WO2016073157A1 (en) 2014-11-06 2016-05-12 Genentech, Inc. Anti-ang2 antibodies and methods of use thereof
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
EA033465B1 (ru) 2015-01-22 2019-10-31 Basf Agro Bv Трехкомпонентная гербицидная комбинация, включающая сафлуфенацил
JP6779887B2 (ja) 2015-01-24 2020-11-04 アカデミア シニカAcademia Sinica 新規なグリカンコンジュゲートおよびその使用方法
CN107407677B (zh) 2015-01-28 2020-07-17 豪夫迈·罗氏有限公司 多发性硬化的基因表达标志和治疗
WO2016138207A1 (en) 2015-02-26 2016-09-01 Genentech, Inc. Integrin beta7 antagonists and methods of treating crohn's disease
US20180208658A1 (en) 2015-04-03 2018-07-26 Eureka Therapeutics, Inc. Constructs targeting afp peptide/mhc complexes and uses thereof
AU2016245807B2 (en) 2015-04-07 2022-05-19 Alector Llc Anti-sortilin antibodies and methods of use thereof
CN104757013A (zh) * 2015-04-18 2015-07-08 广东中迅农科股份有限公司 含有双唑草腈和四唑酰草胺及精噁唑禾草灵的除草组合物
AU2016269839B2 (en) 2015-06-03 2021-07-08 The University Of Queensland Mobilizing agents and uses therefor
CA2988982A1 (en) 2015-06-12 2016-12-15 Alector Llc Anti-cd33 antibodies and methods of use thereof
JP7497953B2 (ja) 2015-06-12 2024-06-11 アレクトル エルエルシー 抗cd33抗体及びその使用方法
US11219212B2 (en) 2015-07-10 2022-01-11 BASF Agro B.V. Herbicidal composition comprising cinmethylin and imazamox
US20180184659A1 (en) 2015-07-10 2018-07-05 BASF Agro B.V. Herbicidal composition comprising cinmethylin and specific pigment synthesis inhibitors
PL3319434T3 (pl) 2015-07-10 2019-11-29 Basf Agro Bv Kompozycja chwastobójcza zawierająca cynmetylinę i petoksamid
JP6875368B2 (ja) 2015-07-10 2021-05-26 ビーエーエスエフ アグロ ベー.ブイ. シンメチリン及びアセトクロール又はプレチラクロールを含む除草剤組成物
KR20180027580A (ko) * 2015-07-10 2018-03-14 바스프 아그로 비.브이. 신메틸린 및 특정한 퀴놀린카르복실산을 포함하는 제초제 조성물
US11219215B2 (en) 2015-07-10 2022-01-11 BASF Agro B.V. Herbicidal composition comprising cinmethylin and specific inhibitors of protoporphyrinogen oxidase
WO2017009056A1 (en) 2015-07-10 2017-01-19 BASF Agro B.V. Herbicidal composition comprising cinmethylin and dimethenamid
PL3319437T3 (pl) 2015-07-10 2020-03-31 BASF Agro B.V. Kompozycja chwastobójcza zawierająca cynmetylinę i piroksasulfon
BR112018000482B1 (pt) 2015-07-10 2022-11-22 BASF Agro B.V. Composição herbicida, uso da composição e método para o controle da vegetação indesejada
CN105076162B (zh) * 2015-08-05 2018-03-09 安徽华星化工有限公司 一种含有乙氧氟草醚和双唑草腈的水稻田除草组合物
EP3341411A1 (en) 2015-08-28 2018-07-04 Alector LLC Anti-siglec-7 antibodies and methods of use thereof
CN117069841A (zh) 2015-10-06 2023-11-17 艾利妥 抗trem2抗体及其使用方法
IL258405B (en) 2015-10-23 2022-09-01 Eureka Therapeutics Inc Antibody/t-cell receptor chimeric structures and their uses
CN116003596A (zh) 2015-10-29 2023-04-25 艾利妥 抗siglec-9抗体及其使用方法
RS65660B1 (sr) 2015-11-25 2024-07-31 Ligachem Biosciences Inc Konјugati koji sadrže samozapaljive grupe i postupci povezani sa njima
JP7008023B2 (ja) 2015-12-30 2022-01-25 ジェネンテック, インコーポレイテッド 低減されたポリソルベート分解を有する製剤
JP7023853B2 (ja) 2016-03-04 2022-02-22 アレクトル エルエルシー 抗trem1抗体及びその使用方法
CN109195996A (zh) 2016-03-08 2019-01-11 中央研究院 N-聚醣及其阵列的模组化合成方法
CN105901005A (zh) * 2016-05-16 2016-08-31 河北博嘉农业有限公司 一种含有双唑草腈的除草组合物
CN105918339A (zh) * 2016-05-19 2016-09-07 河北博嘉农业有限公司 一种含有双唑草腈和磺酰脲类除草剂的除草组合物
WO2018014260A1 (en) 2016-07-20 2018-01-25 Nanjing Legend Biotech Co., Ltd. Multispecific antigen binding proteins and methods of use thereof
EP3500594A4 (en) 2016-08-22 2020-03-11 Cho Pharma Inc. ANTIBODIES, BINDING FRAGMENTS AND METHOD FOR USE
JP7072576B2 (ja) 2016-09-16 2022-05-20 シャンハイ・ヘンリウス・バイオテック・インコーポレイテッド 抗pd-1抗体
WO2018068201A1 (en) 2016-10-11 2018-04-19 Nanjing Legend Biotech Co., Ltd. Single-domain antibodies and variants thereof against ctla-4
CN108064866A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN108064860A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN106561695A (zh) * 2016-11-15 2017-04-19 江苏龙灯化学有限公司 一种除草组合物
CN108064865A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN108064871A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
CN108064868A (zh) * 2016-11-15 2018-05-25 江苏龙灯化学有限公司 一种除草组合物
KR102085798B1 (ko) 2016-12-28 2020-03-06 주식회사 인투셀 베타-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물
US11274157B2 (en) 2017-01-12 2022-03-15 Eureka Therapeutics, Inc. Constructs targeting histone H3 peptide/MHC complexes and uses thereof
WO2018152496A1 (en) 2017-02-17 2018-08-23 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Compositions and methods for the diagnosis and treatment of zika virus infection
CN106889094A (zh) * 2017-02-27 2017-06-27 南京华洲药业有限公司 一种含双唑草腈与吡嘧磺隆的除草组合物及其应用
CN106857577A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与氟硫草定的除草组合物及其应用
CN106857609A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与乙氧嘧磺隆的除草组合物及其应用
CN106889083B (zh) * 2017-02-27 2019-02-12 南京华洲药业有限公司 一种含双唑草腈与异恶草酮的除草组合物及其应用
CN107047593A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与乙氧磺隆的除草组合物及其应用
CN107047592A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与苄嘧磺隆的除草组合物及其应用
CN106889082A (zh) * 2017-02-27 2017-06-27 南京华洲药业有限公司 一种含双唑草腈与噁草酮的除草组合物及其应用
CN107047578A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与丙炔噁草酮的除草组合物及其应用
CN106857578A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与乙草胺的除草组合物及其应用
CN106857621A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与禾草敌的除草组合物及其应用
CN106889084A (zh) * 2017-02-27 2017-06-27 南京华洲药业有限公司 一种含双唑草腈与灭草松的除草组合物及其应用
CN107047582A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与禾草畏的除草组合物及其应用
CN106857575A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与丁草胺的除草组合物及其应用
CN107047594A (zh) * 2017-02-27 2017-08-18 南京华洲药业有限公司 一种含双唑草腈与氯吡嘧磺隆的除草组合物及其应用
CN106857580A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与吡氟酰草胺的除草组合物及其应用
CN106857579A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与三嗪氟草胺的除草组合物及其应用
CN106857576A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与苯噻酰草胺的除草组合物及其应用
CN106857600A (zh) * 2017-02-27 2017-06-20 南京华洲药业有限公司 一种含双唑草腈与异丙隆的除草组合物及其应用
RU2665790C1 (ru) 2017-04-17 2018-09-04 Закрытое Акционерное Общество "Биокад" Моноклональное антитело к pd-l1
US11236151B2 (en) 2017-04-25 2022-02-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antibodies and methods for the diagnosis and treatment of Epstein Barr virus infection
AU2018258046A1 (en) 2017-04-26 2019-12-12 Eureka Therapeutics, Inc. Cells expressing chimeric activating receptors and chimeric stimulating receptors and uses thereof
EP3615574A4 (en) 2017-04-26 2021-02-24 Eureka Therapeutics, Inc. CONSTRUCTIONS SPECIFICALLY RECOGNIZING GLYPICANE 3 AND USES OF SUCH LATEST
US11359014B2 (en) 2017-05-16 2022-06-14 Alector Llc Anti-siglec-5 antibodies and methods of use thereof
CN106954634A (zh) * 2017-05-22 2017-07-18 娄天成 一种含双唑草腈和莎稗磷的农药组合物及其应用
CN107094781A (zh) * 2017-05-22 2017-08-29 孙金金 一种含双唑草腈和二氯喹啉酸的农药组合物及其应用
CN107114382A (zh) * 2017-05-22 2017-09-01 娄天成 一种含双唑草腈和敌稗的农药组合物及其应用
CA3063344A1 (en) 2017-05-23 2018-11-29 Helmholtz Zentrum Munchen - Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) Novel cd73 antibody, preparation and uses thereof
CN107006498A (zh) * 2017-05-24 2017-08-04 江苏省农用激素工程技术研究中心有限公司 用于防除稻田杂草的除草组合物
RU2653545C1 (ru) * 2017-07-17 2018-05-11 АО "Щелково Агрохим" Гербицидная композиция на основе бентазона для защиты зернобобовых культур
US11827669B2 (en) 2017-07-19 2023-11-28 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Antibodies and methods for the diagnosis and treatment of hepatitis b virus infection
CR20190486A (es) 2017-08-03 2020-02-10 Alector Llc Anti-cd33 antibodies and methods of use thereof
MX2019012868A (es) 2017-08-03 2019-11-28 Alector Llc Anticuerpos anti-trem2 y metodos para utilizarlos.
EA039662B1 (ru) 2017-10-03 2022-02-24 Закрытое Акционерное Общество "Биокад" Антитела, специфичные к cd47 и pd-l1
RU2698048C2 (ru) 2017-10-03 2019-08-21 Закрытое Акционерное Общество "Биокад" МОНОКЛОНАЛЬНОЕ АНТИТЕЛО К IL-5Rα
PE20201339A1 (es) 2017-12-19 2020-11-25 Univ Rockefeller Variantes de dominio de fc de igg humana con funcion efectora mejorada
WO2019129221A1 (en) 2017-12-28 2019-07-04 Nanjing Legend Biotech Co., Ltd. Single-domain antibodies and variants thereof against tigit
SG11202004233UA (en) 2018-01-15 2020-06-29 Nanjing Legend Biotech Co Ltd Single-domain antibodies and variants thereof against pd-1
WO2019145475A2 (en) 2018-01-25 2019-08-01 Acm Biolabs Pte Ltd Polymersomes comprising a soluble encapsulated antigen as well as methods of making and uses thereof
CN108371183A (zh) * 2018-02-02 2018-08-07 河北中天邦正生物科技股份公司 一种农药组合物及其应用
CN108308187A (zh) * 2018-02-11 2018-07-24 河北中天邦正生物科技股份公司 一种农药组合物及其应用
AU2019241350A1 (en) 2018-03-30 2020-07-30 Nanjing Legend Biotech Co., Ltd. Single-domain antibodies against LAG-3 and uses thereof
EP3788071A1 (en) 2018-05-02 2021-03-10 The United States Of America, As Represented By The Secretary, Department of Health and Human Services Antibodies and methods for the diagnosis, prevention, and treatment of epstein barr virus infection
CN112469440A (zh) 2018-06-18 2021-03-09 优瑞科生物技术公司 靶向前列腺特异性膜抗原(psma)的构建体和其用途
KR20210031898A (ko) 2018-07-13 2021-03-23 난징 레전드 바이오테크 씨오., 엘티디. 전염병을 치료하기 위한 공동수용체 시스템
EP4212210A1 (en) 2018-07-13 2023-07-19 Alector LLC Anti-sortilin antibodies and methods of use thereof
AU2019310597A1 (en) 2018-07-27 2021-03-11 Alector Llc Anti-siglec-5 antibodies and methods of use thereof
WO2020053325A1 (en) 2018-09-12 2020-03-19 Acm Biolabs Pte Ltd Polymersomes comprising a covalently bound antigen as well as methods of making and uses thereof
RU2724469C2 (ru) 2018-10-31 2020-06-23 Закрытое Акционерное Общество "Биокад" Моноклональное антитело, которое специфически связывается с cd20
BR112021009373A2 (pt) 2018-11-16 2021-08-17 Memorial Sloan Kettering Cancer Center anticorpos para mucina-16 e métodos de uso dos mesmos
RU2734432C1 (ru) 2019-04-23 2020-10-16 Закрытое Акционерное Общество "Биокад" Моноклональное антитело, которое специфически связывается с GITR
JP2022530482A (ja) 2019-05-02 2022-06-29 レゴケム バイオサイエンシズ, インク. トリス構造を有するリンカーを含むリガンド―薬物複合体
MX2021015694A (es) 2019-06-28 2022-03-11 Genentech Inc Composición y métodos para estabilizar formulaciones líquidas de proteínas.
CN110178842A (zh) * 2019-07-05 2019-08-30 南京农业大学 一种丙草胺与双唑草腈治理抗性稗组合物及其应用
CA3147103A1 (en) 2019-07-19 2021-01-28 Oncoresponse, Inc. Immunomodulatory antibodies and methods of use thereof
CN112300279A (zh) 2019-07-26 2021-02-02 上海复宏汉霖生物技术股份有限公司 针对抗cd73抗体和变体的方法和组合物
WO2021238886A1 (en) 2020-05-27 2021-12-02 Staidson (Beijing) Biopharmaceuticals Co., Ltd. Antibodies specifically recognizing nerve growth factor and uses thereof
US20240092926A1 (en) 2021-01-20 2024-03-21 Oncoresponse, Inc. Immunomodulatory antibodies and uses thereof
WO2022218957A1 (en) 2021-04-12 2022-10-20 Acm Biolabs Pte Ltd Polymersomes comprising a soluble encapsulated polynucleotide and an ionizable lipid as well as methods of making and uses thereof
TW202317633A (zh) 2021-07-08 2023-05-01 美商舒泰神(加州)生物科技有限公司 特異性識別tnfr2的抗體及其用途
WO2023284714A1 (zh) 2021-07-14 2023-01-19 舒泰神(北京)生物制药股份有限公司 特异性识别cd40的抗体及其应用
WO2023103788A1 (zh) 2021-12-06 2023-06-15 北京三诺佳邑生物技术有限责任公司 特异性结合肺炎克雷伯菌o2抗原和o1抗原的双特异性抗体以及组合物
TW202417503A (zh) 2022-07-19 2024-05-01 美商舒泰神(加州)生物科技有限公司 特異性識別b和t淋巴細胞衰減器(btla)的抗體及其應用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103678A (en) * 1991-11-13 1996-09-12 Schering Ag History of pyrazolylpyrazole, processes for their preparation and herbicidal preparations containing them
AU676213B2 (en) * 1992-10-12 1997-03-06 Yashima Chemical Industry Co. Ltd. New substituted pyrazole derivatives, processes for their preparation and their use as herbicides

Also Published As

Publication number Publication date
BR9611478A (pt) 1999-07-13
TW355125B (en) 1999-04-01
CA2236592A1 (en) 1997-05-22
US6013605A (en) 2000-01-11
EP0863705B1 (de) 2002-06-12
TR199800794T2 (xx) 1998-08-21
MY114731A (en) 2002-12-31
CN1084148C (zh) 2002-05-08
DE19544393A1 (de) 1997-05-22
CN1201370A (zh) 1998-12-09
JP2000500445A (ja) 2000-01-18
ES2178720T3 (es) 2003-01-01
AU7569696A (en) 1997-06-05
KR19990067314A (ko) 1999-08-16
KR100427960B1 (ko) 2005-01-15
WO1997017852A1 (de) 1997-05-22
EP0863705A1 (de) 1998-09-16
MX9803824A (es) 1998-09-30
CA2236592C (en) 2005-01-04
JP3920341B2 (ja) 2007-05-30
AU711841B2 (en) 1999-10-21
UA48203C2 (uk) 2002-08-15
DE59609348D1 (de) 2002-07-18
RU2170017C2 (ru) 2001-07-10

Similar Documents

Publication Publication Date Title
ZA969564B (en) Synergistic herbicidal mixtures
HUP9900173A3 (en) Herbicidal mixtures having a synergistic effect
HK1009401A1 (en) Synergistic combinations
SI1652433T2 (sl) Herbicidni sestavki
AU1372997A (en) Synergistic insecticidal mixtures
ZA948720B (en) Herbicidal substituted phenylaminosulphonylureas
ZA953065B (en) Insecticidal mixtures
IL119070A0 (en) Synergistic fungicidal compositions
ZA933374B (en) Synergistic herbicide combinations
IL116332A0 (en) Synergistic fungicidal mixtures
HUP9901686A3 (en) Fungicidal mixtures
ZA956265B (en) Herbicidal mixtures
IL114704A0 (en) 4-phenoxycoumarins as herbicidal agents
ZA969798B (en) Herbicidal composition
ZA96400B (en) Herbicidal composition
ZA964324B (en) Herbicidal substituted 3-aryl-pyrazoles
IL124995A0 (en) Herbicidal compositions
PL322102A1 (en) Fungicidal mixtures
GR3032558T3 (en) Fungicide mixtures
US5668087C1 (en) Herbicidal 1-alkenyltetrazolinones
IL122400A0 (en) Fungicidal mixtures
IL111146A0 (en) Aryloxybenzene herbicidal agents
IL123896A0 (en) Fungicidal mixtures
IL126233A (en) Synergistic fungicidal mixtures
ZA984938B (en) Herbicidal mixtures